Growth Metrics

Alto Neuroscience (ANRO) Long-Term Debt Issuances (2024 - 2025)

Alto Neuroscience has reported Long-Term Debt Issuances over the past 2 years, most recently at -$18.9 million for Q3 2025.

  • Quarterly results put Long-Term Debt Issuances at -$18.9 million for Q3 2025, down 1556.77% from a year ago — trailing twelve months through Mar 2026 was -$18.9 million (down 184.97% YoY), and the annual figure for FY2025 was $750000.0, changed.
  • Long-Term Debt Issuances reached -$18.9 million in Q3 2025 per ANRO's latest filing, down from $19.7 million in the prior quarter.
  • Across five years, Long-Term Debt Issuances topped out at $19.7 million in Q1 2025 and bottomed at -$18.9 million in Q3 2025.